NCT06424808

Brief Summary

The investigators aim to evaluate the improvement of the inpatient experience and the usability of a content-based tool (a brochure). This involves consolidating video content for inpatients on a single website and providing access to it via QR codes in a brochure format. \[Patients\] Considering this as a pilot study, the investigators plan to recruit around 30 participants. Both the experimental and control groups will receive standard care and information, with the experimental group additionally receiving the brochure. Random assignment will be used for the experimental and control groups. Surveys and interviews will be conducted to assess changes in patient experience and usability before and after providing the brochure. \[Medical Staff\] Among the medical staff involved in the liver transplant surgical process, researchers will select participants based on their degree of involvement with the intervention subjects. After obtaining their consent, interviews will be conducted concerning patient experiences and the brochure.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

May 21, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 22, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

May 22, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

May 10, 2024

Last Update Submit

May 16, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Inpatient Experience 1

    Inpatient Experience Evaluation Score, which ranges from a minimum of 0 to a maximum of 100 points, with higher scores indicating better patient experiences.

    During the intervention

  • Inpatient Experience 2

    Analysis of survey response trends and frequencies between the experimental and control groups

    During the intervention

  • Inpatient Experience 3

    Qualitative research through interviews

    Patient: During the intervention and after intervention(Two times)/Medical staff: During the study period

Secondary Outcomes (4)

  • Informational value of the intervention tool

    During the intervention

  • Usability value of the intervention tool

    During the intervention

  • Regarding utilization of the intervention tool

    During the intervention

  • Areas for improvement

    During the intervention

Study Arms (2)

Control Group

NO INTERVENTION

1. The group assigned as the control group will receive information in the same manner as it is currently provided to patients. 2. A survey related to patient experience evaluation will be conducted before discharge. The survey will take about 10 minutes. 3. The control group will undergo two interviews, one during hospitalization and one before discharge. Each interview will last approximately 30 minutes. Interviews will be recorded or transcribed, and the recordings will be used until the research objectives are met, after which they will be disposed of.

Experimental Group

EXPERIMENTAL

1. The group assigned as the experimental group will receive information in the same manner as it is currently provided to patients, with the addition of a brochure provided once when moving to a general ward after surgery. The brochure can then be used freely. 2. A survey related to patient experience evaluation will be conducted before discharge. For the experimental group, an additional survey regarding the provided brochure will be included. The survey will take about 15 minutes. 3. The experimental group will undergo two interviews, one during hospitalization and one before discharge. Each interview will last approximately 30 minutes. Interviews will be recorded or transcribed, and the recordings will be used until the research objectives are met, after which they will be disposed of.

Other: Consolidating content on a single website and providing access to it via QR codes in a brochure format

Interventions

The group assigned to the experimental group will receive information in the same manner as current patients do, with the addition of receiving a brochure once when moving to a general ward after surgery. Afterward, they are free to use the brochure. The control group will receive information only in the manner currently provided to patients.

Experimental Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \[Patients\]
  • Adults aged 18 and over
  • Patients who are scheduled to undergo or have undergone liver transplant surgery
  • Recruited through a call for research participants and have consented to participate in this study
  • \[Medical Staff\]
  • Adults aged 18 and over
  • Medical staff at Samsung Medical Center involved in the post-liver transplant treatment process

You may not qualify if:

  • \[Patients\]
  • Individuals who have not consented to participate in this study
  • Individuals whose health condition makes it difficult to participate in the intervention
  • During the research period, the researcher will check if the brochure content has been shared during surveys or interviews with the research participants (information dissemination). If information dissemination is confirmed, the participant will be excluded from the study.
  • \[Medical Staff\]
  • Individuals who have not consented to participate in this study
  • Medical staff not involved in the liver transplant treatment process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Su Min Kim, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 10, 2024

First Posted

May 22, 2024

Study Start

May 21, 2024

Primary Completion

October 31, 2024

Study Completion

November 30, 2024

Last Updated

May 22, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
From the start to the end of the study
Access Criteria
Shared with all researchers approved by the IRB